ArticleBMC neurology2025
Burden of risk factors attributable to Alzheimer's disease and other dementia and its relationship with the Socio-Demographic index in Asia.
Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDementia is an increasingly significant public health challenge worldwide, with Alzheimer’s disease being the most prevalent form of dementia. The objective of this study was burden of risk factors attributable to Alzheimer’s disease and other dementia and its relationship with the Socio-Demographic Index in Asian countries.
methodsThe present study is a population-based study. The 2021 Global Burden of Disease Study dataset for countries in the Asian continent was used in this study. Age-standardized rate (ASR) for incidence, mortality, prevalence, Disability-Adjusted Life Years (DALY), Years of Life Lost (YLL), Years Lived with Disability (YLD) and Annual Percentage Change (APC) were considered by gender and country. We assessed the trend for all index from 2010 to 2021. In addition, the association between socio-demographic index (SDI) and Alzheimer’s disease incidence and prevalnce was calculated using Pearson correlation analysis.
resultsThe results indicated that the number and ASR of four indicators (incidence, prevalence, mortality, DALY, YLL, and YLD) from 1990 to 2021 were higher for women than for men. Metabolic risks and high fasting plasma glucose emerged as the primary risk factors for all four indicators. The percentage change in the risk factor associated with smoking for all four indicators decreased from 1990 to 2021, while the most significant increase was observed in the percentage change related to high body mass index. Additionally, the results demonstrated a positive and significant correlation between the Sociodemographic Index (SDI) and Age-Standardized Incidence Rate (ASIR) (r = 0.284, p = 0.04) as well as Age-Standardized Prevalence Rate (ASPR) (r = 0.281, p = 0.01).
conclusionAccording to the reported results, the burden of disease remains high in most countries. To alleviate this burden, it is essential to prioritize women and the elderly, and to implement more effective prevention and treatment measures.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.